Last Close
Jun 17  •  04:00PM ET
10.65
Dollar change
0.00
Percentage change
0.00
%
Index
-
P/E
37.28
EPS (ttm)
0.29
Insider Own
19.52%
Shs Outstand
19.78M
Perf Week
-0.09%
Market Cap
261.81M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
19.78M
Perf Month
-0.47%
Enterprise Value
260.54M
PEG
-
EPS next Q
-
Inst Own
74.73%
Perf Quarter
-0.47%
Income
7.02M
P/S
-
EPS this Y
-
Inst Trans
-
Perf Half Y
0.47%
Sales
0.00M
P/B
1.33
EPS next Y
-
ROA
3.49%
Perf YTD
0.66%
Book/sh
7.98
P/C
204.54
EPS next 5Y
-
ROE
3.65%
52W High
10.74 -0.80%
Perf Year
0.57%
Cash/sh
0.05
P/FCF
-
EPS past 3/5Y
- -
ROIC
3.58%
52W Low
10.30 3.40%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
- -
Gross Margin
-
Volatility
0.05% 0.20%
Perf 5Y
-
Dividend TTM
-
EV/Sales
-
EPS Y/Y TTM
-
Oper. Margin
-
ATR (14)
0.04
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.87
Sales Y/Y TTM
-
Profit Margin
-
RSI (14)
49.81
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.87
EPS Q/Q
-16.00%
SMA20
-0.04%
Beta
-0.00
Target Price
-
Payout
0.00%
Debt/Eq
0.00
Sales Q/Q
-
SMA50
0.01%
Rel Volume
0.09
Prev Close
10.65
Employees
3
LT Debt/Eq
0.00
Earnings
-
SMA200
0.90%
Avg Volume
23.02K
Price
10.65
IPO
Dec 16, 2024
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
2,162
Change
0.00%
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
CEO & DirectorMr. Zaid Pardesi
CFOMr. George A. Martinez
Chief Operation OfficerMr. Mathew M. Pendo